Results 241 to 250 of about 2,028,087 (333)

Infrastructure and current practice of blood culture diagnostics in patients with sepsis: teachings and recommendations from the European Sepsis Care Survey. [PDF]

Crit Care
Scheer CS, Annane D, Artigas A, Linder A, Sander M, Demirkiran O, Reinhart K, Giamarellos-Bourboulis EJ, Steering Committee of the European Sepsis Alliance.   +8 more
europepmc   +1 more source

A MICROBIOLOGICAL DETERMINATION OF ALANINE

, 1949
Howerde E. Sauberlich, C.A. Baumann
openalex   +1 more source

Standardization of Terminology, Definitions, and Outcome Criteria for Bleeding in Hereditary Hemorrhagic Telangiectasia: International Consensus Report

American Journal of Hematology, EarlyView.
ABSTRACTHereditary hemorrhagic telangiectasia (HHT, Osler‐Weber‐Rendu disease) is the second most common inherited bleeding disorder worldwide, affecting approximately 1 in 5000 people. Development of disease‐modifying and efficacious hemostatic agents to treat HHT has finally begun after decades without such medical therapies.
Hanny Al‐Samkari, Raj S. Kasthuri, Hans‐Jurgen Mager, Jenny Y. Zhou, Marcelo M. Serra, Bethany T. Samuelson‐Bannow, Layla N. Van Doren, Jay F. Piccirillo, Marianne S. Clancy, Keith R. McCrae, Sonia M. Thomas, Antoni Riera‐Mestre, Allyson M. Pishko, Sarah Sewaralthahab, James R. Gossage, Vivek N. Iyer, Cedric Hermans, Adrienne Hammill, Ingrid Winship, Meir Mei‐Zahav, Annette von Drygalski, Scott Olitsky, Marie E. Faughnan   +22 more
wiley   +1 more source

AIM: AI for microbiology. [PDF]

Natl Sci Rev
Wang J, Gao GF.
europepmc   +1 more source

Library Holiday Hours, Subscription to Microbiology, JAMA & Archives, Vol 9 (11) [PDF]

, 2011
Texas Medical Center Library
core   +1 more source

Determinants of 15‐Year Progression‐Free Survival in Multiple Myeloma; Real‐World Data From a Single Institution

American Journal of Hematology, EarlyView.
9% of patients with multiple myeloma achieve 15‐year progression‐free survival; Kaplan‐Meier curves for PFS (A) and OS (B). ABSTRACT The therapeutic advances during the last two decades have rendered multiple myeloma a chronic disease and, thus, it is important to identify patient subgroups which may have extremely favorable outcomes and optimize their
Meletios A. Dimopoulos, Ioannis Ntanasis‐Stathopoulos, Despina Fotiou, Foteini Theodorakakou, Eirini Solia, Vasiliki Spiliopoulou, Panagiotis Malandrakis, Erasmia Psimenou, Stavroula Giannouli, Nikolaos Kanellias, Vassilis Koutoulidis, Maria Roussou, Angeliki Andrikopoulou, Magdalini Migkou, Evangelos Eleutherakis‐Papaiakovou, Maria Gavriatopoulou, Evangelos Terpos, Efstathios Kastritis   +17 more
wiley   +1 more source

Epidemiological and clinical analysis, and outcomes of tuberculosis co-infection among people living with HIV in Türkiye (2014-2024) ClinSurv HIV cohort: A large case series. [PDF]

PLoS One
Mert A, Derin O, Zerdali E, Kaya A, Gül Ö, Borcak D, Kurt AF, Koç MM, Kayaaslan B, Batırel A, Gündüz A, Nakir İY, Yörük G, Sevgi DY, Kumbasar Karaosmanoğlu H, Mete B, Özçelik MN, Sarı ND, Akkoyunlu Y, Tabak F.   +19 more
europepmc   +1 more source

Practical Guidance on Clinical Management of Belantamab Mafodotin‐Associated Ocular Events

American Journal of Hematology, EarlyView.
ABSTRACT Importance Belantamab mafodotin (belamaf)‐containing regimens are effective treatment options for patients with relapsed and/or refractory multiple myeloma. Ocular events are a common adverse effect of belamaf treatment, which can be managed by physicians, following appropriate training, to minimize their impact on the patient.
Evangelos Terpos, Suzanne Trudel, María‐Victoria Mateos, Nicolás Alejandre, Kathryn Colby, Meletios A. Dimopoulos, Simona Degli Esposti, Asim V. Farooq, Maria Gavriatopoulou, Francesca Gay, Vania Hungria, K. Martin Kortüm, Xavier Leleu, Sagar Lonial, Hang Quach, Lugui Qiu, Karthik Ramasamy, Kazuhito Suzuki, Katja C. Weisel, Paul Richardson   +19 more
wiley   +1 more source

Humanity's urgent challenges need solutions from systems microbiology. [PDF]

mSystems
Shade A.
europepmc   +1 more source